REGULATORY AGENCY ACTION
The States also raise a Tenth
Amendment/federalism challenge to the
rule. They argue that the FTC has
improperly expanded its own statutory
authority and has usurped the role of
Congress in determining the extent of
federal intervention in the governance of
state activities.
The States further assert that the state
laws declared "unfair" by the FTC are
protected under the state action doctrine
of Parker v. Brown, 317 U1.S. 341
(1943). The Supreme Court in Parker
"...held that the federal antitrust laws do
not prohibit a State 'as sovereign' from
imposing certain anticompetitive
restraints 'as an act of government."'
Lafayette v. Louisiana Power & Light
Co., 435 U.S. 389, 391 (1978). The FTC
counters that it promulgated Eyeglasses
11pursuant to its rulemaking rather than
its antitrust authority, and therefore the
state action doctrine does not apply.
The States also urge that Eyeglasses
II violates the Constitution's Guarantee
Clause and the "guarantee" of freedom
of the States to control their own affairs
by majority rule. The States view
Eyeglasses 1I as a fundamental threat to
state sovereignty because it replaces the
right to self-government with a scheme
of how optometry should be regulated in
each of the States, discounting various
local conditions and the need for special
or different types of regulation. The
States argue that by directly regulating
the "States as States," and prohibiting
them from enforcing existing state laws
or enacting new laws which in any way
conflict with Eyeglasses II, the FTC has
sought to set itself up as a "SuperState," inserting itself into the political
process of each of the States and altering the structure of state government in
our federal system.
On August 15, 1989, the U.S. Court
of Appeals for the District of Columbia
Circuit granted the States' motion for a
stay of the effective date of the
Eyeglasses II Rule. The court found that
the Board and the other petitioners
demonstrated the requisite elements
warranting a stay, i.e., irreparable harm
and likelihood of success on the merits.
The court's order stated that "...with
respect to irreparable harm, it is clear
that 'any time a state is enjoined from
effectuating statutes enacted by
representatives of the people, it suffers a
form of irreparable injury."'
A briefing schedule was set by the
court on September 27, 1989. The States
filed their brief on the merits on
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November 27. Four other briefs have
already been filed at this time. The
FTC's brief was due to be filed on
February 6; six more briefs were scheduled to be filed by March 7. Oral argument is scheduled for May 10.
RECENT MEETINGS:
At its December meeting, the Board
directed Executive Director Karen
Ollinger to send a letter to ARK Group
regarding the use of the diagnostic drug,
Dapiprazole Hydrochloride, stating that
the Board is not interested in seeking
legislation to allow its use by California
optometrists.
Due to inevitable first-year confusion, the Board passed a motion on a
one-time basis to allow optometrists 120
days in which to complete any deficiencies in continuing education for the
1990 renewal period. An extension
through July 1, 1990 was also authorized for satisfaction of the CPR training
requirement, due to lack of notification.
The Board also selected its 1990 officers: Dr. Steven Chun is the new
President; Dr. Tom Nagy is VicePresident; and Dr. Pam Miller is
Secretary.
FUTURE MEETINGS:
May 21-22 in San Diego.
July 5 in Berkeley.
August 13-14 in Sacramento.
November 29-30 in San Francisco.

BUREAU OF
PERSONNEL SERVICES
Office Supervisor: Janelle Wedge
(9/6) 920-6311
The Bureau of Personnel Services
was established within the Department
of Consumer Affairs (DCA) to regulate
those businesses which secure employment or engagements for others for a
fee. The Bureau regulates both employment agencies and nurses' registries.
Businesses which place applicants in
temporary positions or positions which
command annual gross salaries in
excess of $25,000 are exempt from
Bureau regulation; similarly, employerretained agencies are also exempt from
Bureau oversight.
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employment positions. It prepares and administers a licensing examination and issues
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several types of licenses upon fulfillment of the Bureau's requirements.
Approximately 900 agencies are now
licensed by the Bureau.
The Bureau is assisted by an
Advisory Board created by the
Employment Agency Act. This sevenmember Board consists of three representatives from the employment agency
industry and four public members. All
members are appointed for a term of
four years. At this writing, funding has
limited the bureau to two employees.
LEGISLATION:
AB 2113 (Johnson) abolished the
Bureau, effective January I, 1990, by
repealing the entire Employment
Agency Act in the Business and
Professions Code, provisions of law
which provided for the Bureau of
Personnel Services, its funding, and its
examining, licensing, and regulatory
functions, and those provisions which
provided for nurses' registries, prepaid
computer employment agencies, and job
listing services.
The bill reenacts certain of the above
provisions in Title 2.91 of the Civil
Code, sections 18 12.500 et seq., entitled
the Employment Agency, Employment
Counseling, and Job Listing Services
Act. The Act comprehensively regulates
by statute the contents of employment
agency, employment counseling service,
and job listing service contracts, and
advertising and the fees of such agencies. Among other things, the Act
changes existing law by doing the following:
-The Act deletes licensing and regulation by the Bureau.
-Sections 1812.5 11 and 1812.516 of
the Act provide for a three-day cancellation period in which a jobseeker may cancel a contract with an employment counseling service or a job listing service.
-Sections 1812.503 and 1812.515 of
the Act require the filing of a copy of a
required bond with the Secretary of
State rather than requiring filing of the
bond with the Bureau. The principal
sum of the bond shall be $3,000 for an
employment agency, and $10,000 for a
job listing service. The bond shall be for
the benefit of any person or persons
damaged by any violation of the Act or
by fraud, dishonesty, misstatement, misrepresentation, deceit, unlawful acts or
omissions, or failures to provide the services of the employment agency in performance of the contract with the jobseeker, by the employment agency or its

REGULATORY AGENCY ACTION
agents, representatives, or employees
while acting within the scope of their
employment.
-The Act revises standards of conduct for employment agencies, employment counseling services, and job listing
services. Section 1812.504 requires
every employment agency to give a
written contract to every jobseeker from
whom a fee or deposit is to be received,
whether directly or indirectly, and section 1812.516 requires the same of
every job listing service.
-The Act provides that no employment agency or job listing service shall
accept a fee from any jobseeker, or
send any jobseeker for employment,
without having obtained, orally or in
writing, a bona fide job order for
employment.
-Section 1812.523 of the Act makes
certain contracts entered into by reason
of fraud or misrepresentation void and
unenforceable and provides for a cause
of action for damages by any person
injured by reason of a violation of its
provisions.
-Section 1812.524 et seq. of the Act
substantially reenacts the provisions
dealing with nurses' registries.

BOARD OF PHARMACY
Interim Executive Officer:
PatriciaHarris
(916) 445-5014
Pursuant to Business and Professions
Code section 4000 et seq., the Board of
Pharmacy grants licenses and permits to
pharmacists, pharmacies, drug manufacturers, wholesalers and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Chapter 17, Title 16 of the California
Code of Regulations (CCR). To enforce
its regulations, the Board employs fulltime inspectors who investigate accusations and complaints received by the
Board. Investigations may be conducted
openly or covertly as the situation
demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, including professional misconduct and any
acts substantially related to the practice
of pharmacy.

The Board consists of ten members,
three of whom are public. The remaining members are pharmacists, five of
whom must be active practitioners. All
are appointed for four-year terms.
MAJOR PROJECTS:
Regulatory Changes Rejected. The
Office of Administrative Law (OAL)
recently reviewed and rejected three sets
of regulatory changes submitted by the
Board: section 1707.1, which requires
pharmacists to orally consult with
patients whenever a prescription drug is
dispensed for the first time; section
1717(c), which specifies the tasks which
may be performed by an unlicensed person under the supervision of a licensed
pharmacist; and section 1710, which
defines the term "inpatient hospital
pharmacy." (See CRLR Vol. 9, No. 4
(Fall 1989) p. 75 for background information on these changes.)
OAL rejected section 1707.1 because
it failed to meet the clarity standard and
because the Board failed to summarize
and respond to all comments. Specifically, OAL wanted the Board to clarify
both the contents of "medication profiles" which the rule requires pharmacists to keep on all patients, and the term
"patient" for purposes of the rule. The
Board has released a revised version of
section 1707.1 for comments and
planned to resubmit the file to OAL by
the end of January.
OAL also rejected the Board's
amendment to section 1717(c) due to
lack of clarity. Specifically, the phrase
"dispensing and related tasks" was considered unclear. The Board changed the
phrase to include and define the term
"packaging" and released the revised
proposal for the required comment period. The Board planned to resubmit the
rulemaking file to OAL by the end of
January.
The Board's new section 1710,
which defines inpatient hospital pharmacy, was rejected by OAL under the clarity and necessity standards and because
the Board failed to include a transcript,
recording, or minutes of its public hearing. The proposal was amended,
released for comments, and resubmitted
to OAL on December 20.
English Proficiency Examination.
New section 1719, Chapter 17, Title 16
of the CCR, approved by the Board in
July, would require that candidates for
licensure who have been non-U.S. residents for more than ten years to take and
pass the Test of Spoken English in addi-
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tion to satisfying all other licensure
requirements. (See CRLR Vol. 9, No. 4
(Fall 1989) p. 75 and Vol. 9, No. 3
(Summer 1989) p. 67 for background
information.) This proposal, which is
deemed to have a fiscal impact, is awaiting approval by the Department of
Finance at this writing.
Foreign Graduates. Following an
October 25 regulatory hearing, the
Board adopted new section 1720.1,
Chapter 17, Title 16 of the CCR, which
sets forth the acceptable method of
demonstrating curriculum equivalency
for foreign graduates. (See CRLR Vol.
9, No. 4 (Fall 1989) p. 75 for background information.) The Board also
adopted three other regulatory amendments. Revised section 1720(d) requires
foreign graduates to complete the equivalency evaluation process within five
years. Section 1720(c) was amended to
clarify that the file of an applicant who
fails to pay the licensing fee for a twoyear period after passing the licensing
examination will be deemed abandoned.
The Board also adopted a technical
amendment to section 1720(b). The
Board submitted its rulemaking file on
these proposed changes to OAL on
December 20.
"Black Bag" Regulation Also on
October 25, the Board held a public
hearing on the proposed addition of new
section 1751.10. The new section allows
a pharmacist to carry and furnish dangerous drugs, other than controlled substances, to patients in the home setting.
It also allows the pharmacist to furnish
devices for parenteral therapy in the
home, when the dangerous drug or
device is one currently prescribed for
the patient. The Board submitted the
rulemaking file on this change to OAL
on December 8.
Preprinted Prescription Pads. During its October 25 meeting, the Board
discussed a draft regulation on the issue
of preprinted prescription pads. If adopted, the new regulation, section 1717.3,
Chapter 17, Title 16 of the CCR, would
define a "preprinted, multiple check-off
prescription blank" and prohibit a pharmacist from dispensing a controlled substance on these pads. The regulation
would also forbid the pharmacist from
dispensing a dangerous drug or device
from a preprinted, multiple check-off
prescription blank where more than one
item is checked off.
The Board believes the use of these
pads must be regulated because they
lead to mistakes and have a high poten-
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